Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 220

1.

5-year oncological outcomes of targeted axillary sampling in pT1-2N1 breast cancer.

Lee J, Jung JH, Kim WW, Lee RK, Kim HJ, Kim WH, Park JY, Jeong JY, Chae YS, Lee SJ, Park SH, Kim MY, Yang JD, Lee JW, Lee JS, Park HY.

Asian J Surg. 2018 Nov 20. pii: S1015-9584(18)30579-7. doi: 10.1016/j.asjsur.2018.10.004. [Epub ahead of print]

2.

Impact of Epidermal Growth Factor Receptor Mutation on Clinical Outcomes of Nintedanib Plus Docetaxel in Patients with Previously Treated Non-Small Cell Lung Cancer from the Korean Named Patient Program.

Hong SH, An HJ, Kim K, Lee SS, Lee YG, Yuh YJ, Park IC, Chae YS, Jang TW, Kang JH.

Oncology. 2018 Oct 26:1-8. doi: 10.1159/000492472. [Epub ahead of print]

PMID:
30368503
3.

Tumor microenvironmental factors have prognostic significances in advanced gastric cancer.

Ahn B, Chae YS, Kim CH, Lee Y, Lee JH, Kim JY.

APMIS. 2018 Oct;126(10):814-821. doi: 10.1111/apm.12889.

PMID:
30264431
4.

Therapeutic advantage of genetically engineered Salmonella typhimurium carrying short hairpin RNA against inhibin alpha subunit in cancer treatment.

Yoon W, Yoo Y, Chae YS, Kee SH, Kim BM.

Ann Oncol. 2018 Sep 1;29(9):2010-2017. doi: 10.1093/annonc/mdy240.

PMID:
30016386
5.

Elevated Neutrophil-to-Lymphocyte Ratio Predicts Survival in Patients with Advanced Gastric Cancer Treated with Trastuzumab Combination Chemotherapy.

Hwang GY, Baek DW, Cho HJ, Lee SJ, Chae YS, Kang BW, Lee IH, Kim JG, Seo AN, Bae HI, Park KB, Park JY, Kwon OK, Lee SS, Chung HY.

Anticancer Res. 2018 May;38(5):3151-3156.

PMID:
29715156
6.

Prediction of Advanced Axillary Lymph Node Metastases (ypN2-3) Using Breast MR imaging and PET/CT after Neoadjuvant Chemotherapy in Invasive Ductal Carcinoma Patients.

Kim WH, Lee SW, Kim HJ, Chae YS, Jeong SY, Jung JH, Park HY, Lee WK.

Sci Rep. 2018 Feb 16;8(1):3181. doi: 10.1038/s41598-018-21554-z.

7.

Del-1 Expression as a Potential Biomarker in Triple-Negative Early Breast Cancer.

Lee SJ, Lee J, Kim WW, Jung JH, Park HY, Park JY, Chae YS.

Oncology. 2018;94(4):243-256. doi: 10.1159/000485658. Epub 2018 Jan 31.

PMID:
29393238
8.

Background Registration-Based Adaptive Noise Filtering of LWIR/MWIR Imaging Sensors for UAV Applications.

Kim BH, Kim MY, Chae YS.

Sensors (Basel). 2017 Dec 27;18(1). pii: E60. doi: 10.3390/s18010060.

9.

Ultrasound-Guided Restaging and Localization of Axillary Lymph Nodes After Neoadjuvant Chemotherapy for Guidance of Axillary Surgery in Breast Cancer Patients: Experience with Activated Charcoal.

Kim WH, Kim HJ, Jung JH, Park HY, Lee J, Kim WW, Park JY, Chae YS, Lee SJ.

Ann Surg Oncol. 2018 Feb;25(2):494-500. doi: 10.1245/s10434-017-6250-3. Epub 2017 Nov 13.

PMID:
29134374
10.

Phase II, multicentre, randomised trial of eribulin plus gemcitabine versus paclitaxel plus gemcitabine as first-line chemotherapy in patients with HER2-negative metastatic breast cancer.

Park YH, Im SA, Kim SB, Sohn JH, Lee KS, Chae YS, Lee KH, Kim JH, Im YH, Kim JY, Kim TY, Lee KH, Ahn JH, Kim GM, Park IH, Lee SJ, Han HS, Kim SH, Jung KH; Korean Cancer Study Group (KCSG).

Eur J Cancer. 2017 Nov;86:385-393. doi: 10.1016/j.ejca.2017.10.002. Epub 2017 Nov 5.

PMID:
29100193
11.

Combined Adenosquamous and Large Cell Neuroendocrine Carcinoma of the Gallbladder.

Jung J, Chae YS, Kim CH, Lee Y, Lee JH, Kim DS, Yu YD, Kim JY.

J Pathol Transl Med. 2018 Mar;52(2):121-125. doi: 10.4132/jptm.2017.08.20. Epub 2017 Oct 5.

12.

Tumour infiltrating lymphocytes are predictors of lymph node metastasis in early gastric cancers.

Kim JY, Kim CH, Lee Y, Lee JH, Chae YS.

Pathology. 2017 Oct;49(6):589-595. doi: 10.1016/j.pathol.2017.06.003. Epub 2017 Aug 23.

PMID:
28843920
13.

Lymph node status as a prognostic factor in BRCA-positive breast cancer.

Lee J, Park HY, Jung JH, Kim WW, Chae YS, Lee SJ, Lee S, Bae Y.

J Surg Res. 2017 Jul;215:125-131. doi: 10.1016/j.jss.2017.03.065. Epub 2017 Apr 7.

PMID:
28688637
14.

Biological function of long noncoding RNA snaR in HER2-positive breast cancer cells.

Lee J, Park HY, Kim WW, Lee SJ, Jeong JH, Kang SH, Jung JH, Chae YS.

Tumour Biol. 2017 Jun;39(6):1010428317707374. doi: 10.1177/1010428317707374.

PMID:
28653903
15.

Clinical significance of systemic chemotherapy after curative resection of metachronous pulmonary metastases from colorectal cancer.

Park S, Kang BW, Lee SJ, Yoon S, Chae YS, Kim JG, Lee KH, Koh SA, Song HS, Park KU, Kim JY, Heo MH, Ryoo HM, Cho YY, Jo J, Lee JL, Lee SA.

Cancer Chemother Pharmacol. 2017 Jul;80(1):187-193. doi: 10.1007/s00280-017-3348-z. Epub 2017 Jun 8.

PMID:
28597039
16.

Comparison of 5-year oncological outcomes of breast cancer based on surgery type.

Lee J, Jung JH, Kim WW, Chae YS, Lee SJ, Park HY.

ANZ J Surg. 2018 May;88(5):E395-E399. doi: 10.1111/ans.14017. Epub 2017 May 21.

PMID:
28544393
17.

Hyalinizing Cholecystitis and Associated Carcinoma: A Case Report.

Kang Y, Chae YS, Kim CH, Lee Y, Kim DS, Yu YD, Kim JY.

J Pathol Transl Med. 2018 Jan;52(1):64-66. doi: 10.4132/jptm.2016.11.04. Epub 2017 Apr 4. No abstract available.

18.

Multicenter Phase II Clinical Trial of Genexol-PMĀ® with Gemcitabine in Advanced Biliary Tract Cancer.

Kim JY, Do YR, Song HS, Cho YY, Ryoo HM, Bae SH, Kim JG, Chae YS, Kang BW, Baek JH, Kim MK, Lee KH, Park K.

Anticancer Res. 2017 Mar;37(3):1467-1473.

PMID:
28314319
19.

Comparison of the Mismatch Repair System between Primary and Metastatic Colorectal Cancers Using Immunohistochemistry.

Jung J, Kang Y, Lee YJ, Kim E, Ahn B, Lee E, Kim JY, Lee JH, Lee Y, Kim CH, Chae YS.

J Pathol Transl Med. 2017 Mar;51(2):129-136. doi: 10.4132/jptm.2016.12.09. Epub 2017 Feb 14.

20.

AQP5 Variants Affect Tumoral Expression of AQP5 and Survival in Patients with Early Breast Cancer.

Lee SJ, Kang BW, Kim JG, Jung JH, Lee J, Kim WW, Park HY, Jeong JH, Jeong JY, Park JY, Park JH, Chae YS.

Oncology. 2017;92(3):153-160. doi: 10.1159/000452715. Epub 2016 Dec 16.

PMID:
27978515
21.

Long Noncoding RNA snaR Regulates Proliferation, Migration and Invasion of Triple-negative Breast Cancer Cells.

Lee J, Jung JH, Chae YS, Park HY, Kim WW, Lee SJ, Jeong JH, Kang SH.

Anticancer Res. 2016 Dec;36(12):6289-6295.

PMID:
27919948
22.

Application of genetically engineered Salmonella typhimurium for interferon-gamma-induced therapy against melanoma.

Yoon W, Park YC, Kim J, Chae YS, Byeon JH, Min SH, Park S, Yoo Y, Park YK, Kim BM.

Eur J Cancer. 2017 Jan;70:48-61. doi: 10.1016/j.ejca.2016.10.010. Epub 2016 Nov 22.

PMID:
27883926
23.

Pilot study of FMC (5-fluorouracil, mitomycin C, and cisplatin) with radiotherapy for patients with anal cancer.

Lee IH, Lee SJ, Kang BW, Chae YS, Baek D, Hwang S, Kim HJ, Park SY, Park JS, Choi GS, Kim JC, Kim JG.

Cancer Chemother Pharmacol. 2016 Dec;78(6):1263-1267. doi: 10.1007/s00280-016-3185-5. Epub 2016 Nov 9.

PMID:
27830320
24.

Clinicopathologic Characteristics and Mutational Status of Succinate Dehydrogenase Genes in Paraganglioma of the Urinary Bladder: A Multi-Institutional Korean Study.

Park S, Kang SY, Kwon GY, Kwon JE, Kim SK, Kim JY, Kim CH, Kim HJ, Moon KC, Pyo JY, Park WY, Park ES, Sung JY, Sung SH, Oh YH, Lee SE, Lee W, Lee JI, Cho NH, Jung SJ, Cho MS, Cho YM, Cho HY, Cha EJ, Chae YS, Choe G, Choi YJ, Huh J, Ro JY.

Arch Pathol Lab Med. 2017 May;141(5):671-677. doi: 10.5858/arpa.2016-0403-OA. Epub 2016 Nov 7.

PMID:
27819762
25.

Fibronectin on circulating extracellular vesicles as a liquid biopsy to detect breast cancer.

Moon PG, Lee JE, Cho YE, Lee SJ, Chae YS, Jung JH, Kim IS, Park HY, Baek MC.

Oncotarget. 2016 Jun 28;7(26):40189-40199. doi: 10.18632/oncotarget.9561.

26.

ApCPEB4, a non-prion domain containing homolog of ApCPEB, is involved in the initiation of long-term facilitation.

Lee SH, Shim J, Cheong YH, Choi SL, Jun YW, Lee SH, Chae YS, Han JH, Lee YS, Lee JA, Lim CS, Si K, Kassabov S, Antonov I, Kandel ER, Kaang BK, Jang DJ.

Mol Brain. 2016 Oct 22;9(1):91.

27.

Prognostic Value of Axillary Nodal Ratio after Neoadjuvant Chemotherapy of Doxorubicin/Cyclophosphamide Followed by Docetaxel in Breast Cancer: A Multicenter Retrospective Cohort Study.

Kim SH, Jung KH, Kim TY, Im SA, Choi IS, Chae YS, Baek SK, Kang SY, Park S, Park IH, Lee KS, Choi YJ, Lee S, Sohn JH, Park YH, Im YH, Ahn JH, Kim SB, Kim JH.

Cancer Res Treat. 2016 Oct;48(4):1373-1381. Epub 2016 Mar 23.

28.

Does Polymerase Chain Reaction of Tissue Specimens Aid in the Diagnosis of Tuberculosis?

Lee YJ, Kim S, Kang Y, Jung J, Lee E, Kim JY, Lee JH, Lee Y, Chae YS, Kim CH.

J Pathol Transl Med. 2016 Nov;50(6):451-458. Epub 2016 Oct 10.

29.

Clinical impact of induction treatment modalities and optimal timing of radiotherapy for the treatment of limited-stage NK/T cell lymphoma.

Moon JH, Lee BH, Kim JA, Lee YJ, Chae YS, Yhim HY, Kwak JY, Do YR, Park Y, Song MK, Shin HJ, Kim T, Lee JJ, Yang DH.

Leuk Res. 2016 Oct;49:80-7. doi: 10.1016/j.leukres.2016.08.015. Epub 2016 Aug 31.

PMID:
27608179
30.

Five-Year Oncologic Outcomes of Volume Displacement Procedures After Partial Mastectomy for Breast Cancer.

Lee J, Jung JH, Kim WW, Hwang SO, Chae YS, Lee SJ, Yang JD, Lee JW, Park HY.

Clin Breast Cancer. 2017 Feb;17(1):70-75. doi: 10.1016/j.clbc.2016.06.018. Epub 2016 Jun 29.

PMID:
27461450
31.

Predicting Extrathyroidal Extension in Patients With Papillary Thyroid Microcarcinoma According to a BRAF Mutation.

Lee DY, Hwang SM, An JH, Son KR, Baek SK, Kim SG, Chae YS, Jung KY.

Clin Exp Otorhinolaryngol. 2017 Jun;10(2):174-180. doi: 10.21053/ceo.2015.01655. Epub 2016 Jul 2.

32.

Impact of Genetic Variation in MicroRNA-binding Site on Susceptibility to Colorectal Cancer.

Kang BW, Jeon HS, Chae YS, Lee SJ, Park JS, Choi GS, Kim JG.

Anticancer Res. 2016 Jul;36(7):3353-61.

PMID:
27354594
33.

Facile Route to NiO Nanostructured Electrode Grown by Oblique Angle Deposition Technique for Supercapacitors.

Kannan V, Inamdar AI, Pawar SM, Kim HS, Park HC, Kim H, Im H, Chae YS.

ACS Appl Mater Interfaces. 2016 Jul 13;8(27):17220-5. doi: 10.1021/acsami.6b03714. Epub 2016 Jul 1.

PMID:
27322601
34.

Morphometric Analysis of Thyroid Follicular Cells with Atypia of Undetermined Significance.

Kang Y, Lee YJ, Jung J, Lee Y, Won NH, Chae YS.

J Pathol Transl Med. 2016 Jul;50(4):287-93. doi: 10.4132/jptm.2016.04.04. Epub 2016 Jun 13.

35.

Tumor microenvironment-specific nanoparticles activatable by stepwise transformation.

Ko H, Son S, Jeon J, Thambi T, Kwon S, Chae YS, Kang YM, Park JH.

J Control Release. 2016 Jul 28;234:68-78. doi: 10.1016/j.jconrel.2016.05.009. Epub 2016 May 6.

PMID:
27164544
36.

Pilot Study of Neoadjuvant Chemoradiotherapy with Three Cycles of 5-Fluorouracil Plus Leucovorin for Treatment of Locally Advanced Rectal Cancer.

Lee SJ, Kang BW, Chae YS, Kim HJ, Park SY, Park JS, Choi GS, Kim JG.

Ann Surg Oncol. 2016 Mar;23(3):894-9. doi: 10.1245/s10434-015-4946-9. Epub 2015 Dec 29.

PMID:
26714957
37.

A pH-responsive carboxymethyl dextran-based conjugate as a carrier of docetaxel for cancer therapy.

Han HS, Lee M, An JY, Son S, Ko H, Lee H, Chae YS, Kang YM, Park JH.

J Biomed Mater Res B Appl Biomater. 2016 May;104(4):789-96. doi: 10.1002/jbm.b.33581. Epub 2015 Dec 21.

PMID:
26687579
38.

The role of preoperative breast magnetic resonance (MR) imaging for surgical decision in patients with triple-negative breast cancer.

Lee J, Jung JH, Kim WW, Hwang SO, Kim HJ, Park JY, Chae YS, Yang JD, Park HY.

J Surg Oncol. 2016 Jan;113(1):12-6. doi: 10.1002/jso.24102. Epub 2015 Dec 2.

PMID:
26625879
39.

Pre- and post-ESD discrepancies in clinicopathologic criteria in early gastric cancer: the NECA-Korea ESD for Early Gastric Cancer Prospective Study (N-Keep).

Kim JM, Sohn JH, Cho MY, Kim WH, Chang HK, Jung ES, Kook MC, Jin SY, Chae YS, Park YS, Kang MS, Kim H, Lee JH, Park do Y, Kim KM, Kim H, Kim YW, Hwang SS, Seol SY, Jung HY, Lee NR, Park SH, You JH.

Gastric Cancer. 2016 Oct;19(4):1104-13. doi: 10.1007/s10120-015-0570-4. Epub 2015 Nov 30.

40.

Identification of Developmental Endothelial Locus-1 on Circulating Extracellular Vesicles as a Novel Biomarker for Early Breast Cancer Detection.

Moon PG, Lee JE, Cho YE, Lee SJ, Jung JH, Chae YS, Bae HI, Kim YB, Kim IS, Park HY, Baek MC.

Clin Cancer Res. 2016 Apr 1;22(7):1757-66. doi: 10.1158/1078-0432.CCR-15-0654. Epub 2015 Nov 24.

41.

Differential Toxicokinetics Determines the Sensitivity of Two Marine Embryonic Fish Exposed to Iranian Heavy Crude Oil.

Jung JH, Kim M, Yim UH, Ha SY, Shim WJ, Chae YS, Kim H, Incardona JP, Linbo TL, Kwon JH.

Environ Sci Technol. 2015 Nov 17;49(22):13639-48. doi: 10.1021/acs.est.5b03729. Epub 2015 Nov 9.

PMID:
26458192
42.

Gold-installed biostable nanocomplexes for tumor-targeted siRNA delivery in vivo.

Heo R, Yoon HY, Ko H, Shin JM, Jeon J, Chae YS, Kang YM, Kim D, Lee DS, Park JH.

Chem Commun (Camb). 2015 Dec 4;51(93):16656-9. doi: 10.1039/c5cc05639j. Epub 2015 Oct 1.

PMID:
26426483
43.

A phase II study of oxaliplatin and prednisone for patients with relapsed or refractory marginal zone lymphoma: Consortium for Improving Survival of Lymphoma trial.

Oh SY, Kim WS, Kim JS, Chae YS, Lee GW, Eom HS, Ryoo HM, Lee S, Kim SJ, Yoon DH, Won JH, Hong J, Park J, Lee SM, Hong JY, Park E, Kim HJ, Yang DH, Kim HJ, Suh C.

Leuk Lymphoma. 2016;57(6):1406-12. doi: 10.3109/10428194.2015.1099650. Epub 2015 Nov 16.

PMID:
26413982
44.

X-ray and optical stereo-based 3D sensor fusion system for image-guided neurosurgery.

Kim DN, Chae YS, Kim MY.

Int J Comput Assist Radiol Surg. 2016 Apr;11(4):529-41. doi: 10.1007/s11548-015-1290-2. Epub 2015 Sep 26.

PMID:
26410838
45.

Whole-Body Metabolic Tumor Volume, as Determined by (18)F-FDG PET/CT, as a Prognostic Factor of Outcome for Patients With Breast Cancer Who Have Distant Metastasis.

Son SH, Lee SW, Jeong SY, Song BI, Chae YS, Ahn BC, Lee J.

AJR Am J Roentgenol. 2015 Oct;205(4):878-85. doi: 10.2214/AJR.14.13906. Epub 2015 Jul 23.

PMID:
26204115
46.

Multi-center Randomized Phase II Study of Weekly Docetaxel Versus Weekly Docetaxel-plus-Oxaliplatin as a Second-line Chemotherapy for Patients with Advanced Gastric Cancer.

Kim JY, Ryoo HM, Bae SH, Kang BW, Chae YS, Yoon S, Baek JH, Kim MK, Lee KH, Lee SA, Song HS, Kim JG.

Anticancer Res. 2015 Jun;35(6):3531-6.

PMID:
26026121
47.

Aquaporin 3 Expression Predicts Survival in Patients with HER2-positive Early Breast Cancer.

Kang S, Chae YS, Lee SJ, Kang BW, Kim JG, Kim WW, Jung JH, Park HY, Jeong JH, Jeong JY, Park JY.

Anticancer Res. 2015 May;35(5):2775-82.

PMID:
25964557
48.

Clinical Outcomes and Prognostic Factors of Up-Front Autologous Stem Cell Transplantation in Patients with Extranodal Natural Killer/T Cell Lymphoma.

Yhim HY, Kim JS, Mun YC, Moon JH, Chae YS, Park Y, Jo JC, Kim SJ, Yoon DH, Cheong JW, Kwak JY, Lee JJ, Kim WS, Suh C, Yang DH; Consortium for Improving Survival of Lymphoma Study.

Biol Blood Marrow Transplant. 2015 Sep;21(9):1597-604. doi: 10.1016/j.bbmt.2015.05.003. Epub 2015 May 8.

49.

Pilot study of modified FOLFOX6 adjuvant chemotherapy for high-risk rectal cancer treated with neoadjuvant chemoradiotherapy.

Lee SJ, Kang BW, Chae YS, Cho SH, Kim HJ, Park SY, Park JS, Choi GS, Kim JG.

Cancer Chemother Pharmacol. 2015 Jul;76(1):29-34. doi: 10.1007/s00280-015-2764-1. Epub 2015 May 9.

PMID:
25956708
50.

Prognostic significance of interim PET/CT based on visual, SUV-based, and MTV-based assessment in the treatment of peripheral T-cell lymphoma.

Jung SH, Ahn JS, Kim YK, Kweon SS, Min JJ, Bom HS, Kim HJ, Chae YS, Moon JH, Sohn SK, Lee SW, Byun BH, Do YR, Lee JJ, Yang DH.

BMC Cancer. 2015 Mar 28;15:198. doi: 10.1186/s12885-015-1193-1.

Supplemental Content

Support Center